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Bacteria tear down microtubules
 
any invasive bacteria let themselves 
into host cells, not bothering to wait  M
 
for an invitation. So far, known effector 
proteins that allow 
bacteria to enter work by 
rearranging actin dy-
namics. But new research 
from Sei Yoshida, Chihiro 
Sasakawa (University of 
Tokyo, Tokyo), and 
colleagues reveals that 
 
Shigella
 
 bacteria have 
another trick up their 
proverbial sleeves. They 
destabilize microtubules 
(MTs) to promote their 
own phagocytosis.
 
Arteries play follow the leader
 
rteries branch and extend 
in an intricate pattern 
worthy of a Michelangelo 
painting. But it’s more like a 
tracing than an original work 
of art, according to new results 
from Yoh-suke Mukouyama, 
David Anderson (California 
Institute of Technology, 
Pasadena, CA), and colleagues. 
They find that the original 
artwork is the nerve network.
Anderson’s group observed 
that peripheral nerves in the limbs of mice are aligned along 
arterial vessels. More than a coincidental association, the 
presence of these nerves actually specified arterial differentiation. 
When nerves were misrouted, arteries became similarly 
patterned along the altered nerve route. Veins, on the other 
hand, were not affected. “Nerves in limbs go where the 
action is, to muscle and skin,” says Anderson. “There’s 
a lot of metabolic activity there that needs oxygen. So it 
makes sense that arteries would take the same path taken 
by nerves.”
Nerve cells probably direct arterial organization and formation 
by secreting the endothelial mitogen VEGF. In vitro, VEGF 
induced arterial differentiation of endothelial cells, and mutant 
mice that lack Schwann cells and whose arteries and nerves 
had lost their association also had reduced expression of 
VEGF in their nerve cells. Anderson plans to confirm VEGF 
involvement in this process by examining mice that completely 
lack VEGF expression in peripheral nerves.
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Arteries (pink) grow 
alongside nerves (green) 
in the skin.
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Shigella
 
 uses the Type III secretion 
system to deliver a set of its effector 
proteins into cells it plans to invade. 
Some of these proteins 
act in well-known ways 
to modulate the actin 
cytoskeleton. For instance, 
IpaA binds the focal 
adhesion protein vinculin, 
and this complex promotes 
actin depolymerization. But 
the group focused on VirA, 
which acts independently 
of other effectors. 
 
Shigella
 
 
lacking VirA are 70–80% 
less invasive than wild-type 
bacteria.
The authors found that VirA bound 
 
 
 
/
 
 
 
-tubulin heterodimers and destabilized 
MTs in vitro and in vivo. Destabilization 
led to membrane ruffling around the 
bacterium, an effect that was dependent 
on the activation of Rac1. Sasakawa is 
not yet sure how VirA binding causes 
MT instability. Bound heterodimers may 
be held less stably in the MT lattice, or 
VirA might compete with MTs for 
binding to tubulin heterodimers. VirA 
homologues exist in other bacteria, 
including 
 
E. coli
 
, indicating that a wide 
range of pathogens may alter MT 
dynamics to aid in their invasion. 
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VirA disrupts microtubules 
(green) and causes 
membrane ruffling.
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Stable globin needs a partner
 
n the absence of a binding partner, such as when 
 
 
 
-globin is 
mutated in 
 
 
 
-thalassemia, the unstable 
 
 
 
-globin protein tends to 
form toxic inclusion bodies. Molecular chaperones that stabilize 
hemoglobin have been proposed to exist, but have not been 
found, until now. Anthony Kihm, Mitchell Weiss, and colleagues 
(University of Pennsylvania, Philadelphia, PA) have now identified 
a protein that protects 
 
 
 
-globin until it can find 
 
 
 
-globin and form 
hemoglobin A (HbA).
This chaperone-like protein, AHSP, was identified in a screen 
for genes induced by the transcription factor GATA-1, which 
promotes erythrocyte differentiation. Many genes were induced 
by GATA-1, but Weiss found AHSP particularly interesting 
because it was strongly and specifically expressed in RBCs and 
had no known function. Screens for protein–protein interactions 
revealed that AHSP bound to 
 
 
 
-globin, but not to 
 
 
 
-globin or HbA.
AHSP prevented 
 
 
 
-globin precipitation 
in cells and in vitro. In mice lacking 
AHSP, erythrocytes contained inclusion 
bodies and turned over more rapidly 
than in wild-type mice. “The phenotype 
of the knock-out mice was relatively 
mild, probably because red cells do a 
good job of balancing the amount of 
 
 
 
- and 
 
 
 
-globin they produce,” says 
Weiss. “So, AHSP is not absolutely 
essential when things are good, but 
may become more important when things aren’t going so well.”
Thus, AHSP could be a genetic modifier of 
 
 
 
-thalassemia. 
Patients with this disease suffer twofold from a lack of 
 
 
 
-globin—
they are unable to make enough HbA for good respiratory capacity, 
and they have an excess of toxic, free 
 
 
 
-globin. If a drug could be 
made to mimic AHSP, it might help offset free 
 
 
 
-globin toxicity. 
This could decrease transfusion requirements in some patients. 
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Without AHSP, 
globin inclusion 
bodies (purple) form.
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